MT 1618 4,7-Dichloroquinoline, [3H]- Click here for Typical Certificate of Analysis |
|
MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 20 Ci(0.74 TBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 198.05 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2071 4-Hydroxyquinoline, [benzene ring-14C]- |
|
| Click here for Typical Certificate of Analysis | |
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
| Solid | |
| > 50 mCi(1.85 GBq)/mmol |
10 µCi (370 kBq) $1240 |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 145.16 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2256 6-Nitro-1,2,3,4-tetrahydroisoquinolinyl-t-butylcarbonate, [14C]- |
|
Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
| Ethanol solution, 100 µCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 278.30  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT
1566 Quinolinic acid, [3H]- |
|
MORpure™ Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
| Ethanol water (1:1) solution, 1mCi/ml | 50 μCi (1.85 MBq) $1160 |
| > 3 Ci(111 GBq)/mmol | 250 μCi (9.25 MBq) $1970 |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 167.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2729 8-Hydroxyquinoline, [phenyl ring-14C(U)]- |
|
| MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Acetonitrile:water (2:8) solution | |
| ≥ 50 mCi (1.85 GBq)/mmol | 10 µCi (370 kBq) $1240 |
| NextGen V-Vial | 50 µCi (1.85 MBq) $3970 |
M.W. 145.16
 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2798 3-(Phenylsulfonyl)-8-(piperazin-1-yl)quinoline, [phenyl-14C(U)]- |
|
| MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Solid | |
| ≥ 10 mCi (370 MBq)/mmol | 10 µCi (370 kBq) $1240 |
| NextGen V-Vial - shipped on dry ice | 50 µCi (1.85 MBq) $3970 |
M.W. 353.44
 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
